About this trial
The aim of this study is to preliminarily evaluate the is to assess the effects and safety of electroacupuncture for moderate to severe dysmenorrhea secondary to adenomyosis.
Eligibility criteria
Qualifiers
Meeting the diagnosis criteria of dysmenorrhea secondary to adenomyosis.
Female patients aged between 18 and 50.
Dysmenorrhea lasting for 3 consecutive menstrual cycles or more.
At least three consecutive menstrual cycles with an interval of 24 to 38 days, differing by less than 7 days, and menstrual periods lasting 2 to 8 days before screening.
Disqualifiers
Diagnosed with Endometriosis or having a history of endometriosis-related surgery
Currently taking hormonal medications, including: a.use of GnRH agonists within 6 months before the screening period; b. use of progestins or danazol and other long-acting hormones within 3 months before the screening period; c. use of oral contraceptive-like short-acting hormones within one month before the screening period;
Having clinically significant gynecologic condition such as clinically significant endometrial pathology, persistent complex ovarian cyst larger than 3 cm or simple ovarian cyst larger than 5 cm, or single fibroid 4 cm or larger or more than 4 fibroids measuring at least 2 cm or symptomatic submucosal fibroid of any size.
having an IUD.
Trial design
Treatments tested in this trial
- Electroacupuncture
- Sham Electroacupuncture